These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38605440)

  • 1. ALKBH5-mediated m6A demethylation of pri-miR-199a-5p exacerbates myocardial ischemia/reperfusion injury by regulating TRAF3-mediated pyroptosis.
    Li J; Wang Z; Tan H; Tang M
    J Biochem Mol Toxicol; 2024 Apr; 38(4):e23710. PubMed ID: 38605440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of ALKBH5-mediated m6A demethylation regulating lipopolysaccharide-induced epithelial-mesenchymal transition in sepsis-induced acute kidney injury.
    Zhao HH; Chen CL; Chen FF; Zhang LL; Li MM; He ZB
    Kaohsiung J Med Sci; 2024 Nov; 40(11):985-995. PubMed ID: 39287046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of METTL3-Mediated m
    Wang X; Li Y; Li J; Li S; Wang F
    Cardiovasc Drugs Ther; 2023 Jun; 37(3):435-448. PubMed ID: 35066738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suxiao Jiuxin Pill alleviates myocardial ischemia/reperfusion-induced autophagy via miR-193a-3p/ALKBH5 pathway.
    Wang D; Wang D; Jin Q; Wang X
    Phytomedicine; 2024 Mar; 125():155359. PubMed ID: 38301300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0050908 up-regulates TRAF3 by sponging miR-324-5p to aggravate myocardial ischemia-reperfusion injury.
    Jin A; Zhang Q; Cheng H; Yang C; Wang X
    Int Immunopharmacol; 2022 Jul; 108():108740. PubMed ID: 35413678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkylation Repair Homolog 5 Regulates N(6)-methyladenosine (m6A) Methylation of Mitsugumin 53 to Attenuate Myocardial Infarction by Inhibiting Apoptosis and Oxidative Stress.
    Li D; Li L; Dong S; Yu Y; Zhang L; Jiang S
    J Cardiovasc Pharmacol; 2024 Feb; 83(2):183-192. PubMed ID: 37989146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin-specific protease 11 Aggravates Ischemia-reperfusion-induced Cardiomyocyte Pyroptosis and Injury by Promoting TRAF3 Deubiquitination.
    Zhang Y; Hailati J; Ma X; Midilibieke H; Liu Z
    Balkan Med J; 2023 May; 40(3):205-214. PubMed ID: 37000116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0000647 promotes cell injury by modulating miR-126-5p/TRAF3 axis in oxygen-glucose deprivation and reperfusion-induced SK-N-SH cell model.
    Dai Y; Sheng Y; Deng Y; Wang H; Zhao Z; Yu X; Xu T
    Int Immunopharmacol; 2022 Mar; 104():108464. PubMed ID: 35021128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL14-mediated N6-methyladenosine modification induces the ferroptosis of hypoxia/reoxygenation-induced cardiomyocytes.
    Zhao C; Li J
    J Cardiothorac Surg; 2024 Apr; 19(1):265. PubMed ID: 38664788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALKBH5 promotes the progression of infantile hemangioma through regulating the NEAT1/miR-378b/FOSL1 axis.
    Peng K; Xia RP; Zhao F; Xiao Y; Ma TD; Li M; Feng Y; Zhou CG
    Mol Cell Biochem; 2022 May; 477(5):1527-1540. PubMed ID: 35182329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA Rian reduces cardiomyocyte pyroptosis and alleviates myocardial ischemia-reperfusion injury by regulating by the miR-17-5p/CCND1 axis.
    Kang H; Yu H; Zeng L; Ma H; Cao G
    Hypertens Res; 2022 Jun; 45(6):976-989. PubMed ID: 35264782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
    Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W
    Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA XIST facilitates hypoxia-induced myocardial cell injury through targeting miR-191-5p/TRAF3 axis.
    Wang Y; Liu Y; Fei A; Yu Z
    Mol Cell Biochem; 2022 Jun; 477(6):1697-1707. PubMed ID: 35257270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALKBH5 activates FAK signaling through m6A demethylation in
    Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
    Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
    [No Abstract]   [Full Text] [Related]  

  • 15. Up-regulating microRNA-138-5p enhances the protective role of dexmedetomidine on myocardial ischemia-reperfusion injury mice via down-regulating Ltb4r1.
    Chang Y; Xing L; Zhou W; Zhang W
    Cell Cycle; 2021 Feb; 20(4):445-458. PubMed ID: 33509010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-199a-5p promotes ferroptosis-induced cardiomyocyte death responding to oxygen-glucose deprivation/reperfusion injury via inhibiting Akt/eNOS signaling pathway.
    Zhang GY; Gao Y; Guo XY; Wang GH; Guo CX
    Kaohsiung J Med Sci; 2022 Nov; 38(11):1093-1102. PubMed ID: 36254861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-30e up-regulation alleviates myocardial ischemia-reperfusion injury and promotes ventricular remodeling via SOX9 repression.
    Cheng N; Li L; Wu Y; Wang M; Yang M; Wei S; Wang R
    Mol Immunol; 2021 Feb; 130():96-103. PubMed ID: 33293097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-Methyladenosine Demethylase ALKBH5 Promotes Pyroptosis by Modulating PTBP1 mRNA Stability in LPS-Induced Myocardial Dysfunction.
    Liu M; Chen X
    Acta Cardiol Sin; 2024 May; 40(3):312-321. PubMed ID: 38779157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALKBH5 induces fibroblast-to-myofibroblast transformation during hypoxia to protect against cardiac rupture after myocardial infarction.
    Yang K; Zhao Y; Hu J; Gao R; Shi J; Wei X; Chen J; Hu K; Sun A; Ge J
    J Adv Res; 2024 Jul; 61():193-209. PubMed ID: 37689242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting MicroRNA-29a Protects Myocardial Ischemia-Reperfusion Injury by Targeting SIRT1 and Suppressing Oxidative Stress and NLRP3-Mediated Pyroptosis Pathway.
    Ding S; Liu D; Wang L; Wang G; Zhu Y
    J Pharmacol Exp Ther; 2020 Jan; 372(1):128-135. PubMed ID: 31481517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.